G protein-coupled receptors in HIV and SIV entry: New perspectives on lentivirus-host interactions and on the utility of animal models

被引:47
作者
Unutmaz, D
KewalRamani, VN
Littman, DR
机构
[1] NYU, Med Ctr, Howard Hughes Med Inst, New York, NY 10016 USA
[2] NYU, Med Ctr, Skirball Inst Biomol Med, Div Mol Pathogenesis, New York, NY 10016 USA
基金
美国国家卫生研究院;
关键词
animal model; chemokine receptor; HIV; SIV;
D O I
10.1006/smim.1998.0134
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Entry of primate lentiviruses into target cells has recently been shown to depend upon, the interaction of the viral envelope glycoprotein with CD4 and one or more members of the G protein-coupled receptor (GPCR) family of transmembrane proteins. In vivo, the transmission of HIV-1 infection generally requires viral strains that utilise chemokine receptor CCR5, and these strains prevail during the early course of infection. Strains isolated later, in the course of progression to immunodeficiency, are often CXCR4-tropic or are dual tropic for both chemokine receptors. SN isolates also use CCR5 but are only rarely specific for CXCR4. Instead, SIVs use two orphan members of the GPCR family, named Bonzo/STRL33/TYMSTR and BOB/GPR15. Strains of HIV-5 which are closely related to the SIVs, also often utilise CXCR4, CCR5, BOB and/or Bonzo. Additional GPCR family members have also been shown to be utilised by various strains of HIV and SIV albeit less efficiently and less frequently. Here we discuss the potential relationship between receptor specificity and viral pathogenesis as well as efforts to develop animal model systems to study the mechanism of disease progression.
引用
收藏
页码:225 / 236
页数:12
相关论文
共 98 条
[41]   GENETIC-VARIATION IN HTLV-III/LAV OVER TIME IN PATIENTS WITH AIDS OR AT RISK FOR AIDS [J].
HAHN, BH ;
SHAW, GM ;
TAYLOR, ME ;
REDFIELD, RR ;
MARKHAM, PD ;
SALAHUDDIN, SZ ;
WONGSTAAL, F ;
GALLO, RC ;
PARKS, ES ;
PARKS, WP .
SCIENCE, 1986, 232 (4757) :1548-1553
[42]   CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia [J].
He, JL ;
Chen, YZ ;
Farzan, M ;
Choe, HY ;
Ohagen, A ;
Gartner, S ;
Busciglio, J ;
Yang, XY ;
Hofmann, W ;
Newman, W ;
Mackay, CR ;
Sodroski, J ;
Gabuzda, D .
NATURE, 1997, 385 (6617) :645-649
[43]   CD4-independent association between HIV-1 gp120 and CXCR4: Functional chemokine receptors are expressed in human neurons [J].
Hesselgesser, J ;
HalksMiller, M ;
DelVecchio, V ;
Peiper, SC ;
Hoxie, J ;
Kolson, DL ;
Taub, D ;
Horuk, R .
CURRENT BIOLOGY, 1997, 7 (02) :112-121
[44]   Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor [J].
Hill, CM ;
Deng, HK ;
Unutmaz, D ;
Kewalramani, VN ;
Bastiani, L ;
Gorny, MK ;
ZollaPazner, S ;
Littman, DR .
JOURNAL OF VIROLOGY, 1997, 71 (09) :6296-6304
[45]  
HILL CM, 1998, IN PRESS VIROLOGY
[46]   RAPID TURNOVER OF PLASMA VIRIONS AND CD4 LYMPHOCYTES IN HIV-1 INFECTION [J].
HO, DD ;
NEUMANN, AU ;
PERELSON, AS ;
CHEN, W ;
LEONARD, JM ;
MARKOWITZ, M .
NATURE, 1995, 373 (6510) :123-126
[47]   The CC chemokine I-309 inhibits CCR8-dependent infection by diverse HIV-1 strains [J].
Horuk, R ;
Hesselgesser, J ;
Zhou, YQ ;
Faulds, D ;
Halks-Miller, M ;
Harvey, S ;
Taub, D ;
Samson, M ;
Parmentier, M ;
Rucker, J ;
Doranz, BJ ;
Doms, RW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) :386-391
[48]   Characterization of gag and pol sequences from long-term survivors of human immunodeficiency virus type 1 infection [J].
Huang, YX ;
Zhang, LQ ;
Ho, DD .
VIROLOGY, 1998, 240 (01) :36-49
[49]   The role of a mutant CCR5 allele in HIV-1 transmission and disease progression [J].
Huang, YX ;
Paxton, WA ;
Wolinsky, SM ;
Neumann, AU ;
Zhang, LQ ;
He, T ;
Kang, S ;
Ceradini, D ;
Jin, ZQ ;
Yazdanbakhsh, K ;
Kunstman, K ;
Erickson, D ;
Dragon, E ;
Landau, NR ;
Phair, J ;
Ho, DD ;
Koup, RA .
NATURE MEDICINE, 1996, 2 (11) :1240-1243
[50]   HUMAN HEMATOLYMPHOID CELLS IN SCID MICE [J].
KANESHIMA, H ;
NAMIKAWA, R ;
MCCUNE, JM .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (02) :327-333